Does CHLORTHALIDONE Cause Bladder transitional cell carcinoma? 22 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Bladder transitional cell carcinoma have been filed in association with CHLORTHALIDONE (Chlorthalidone). This represents 1.3% of all adverse event reports for CHLORTHALIDONE.
22
Reports of Bladder transitional cell carcinoma with CHLORTHALIDONE
1.3%
of all CHLORTHALIDONE reports
0
Deaths
22
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From CHLORTHALIDONE?
Of the 22 reports, 22 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CHLORTHALIDONE. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does CHLORTHALIDONE Cause?
Hyponatraemia (258)
Drug ineffective (209)
Nausea (159)
Hypokalaemia (136)
Dizziness (133)
Acute kidney injury (126)
Oedema peripheral (114)
Vomiting (107)
Hypotension (102)
Dyspnoea (96)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which CHLORTHALIDONE Alternatives Have Lower Bladder transitional cell carcinoma Risk?
CHLORTHALIDONE vs CHLORZOXAZONE
CHLORTHALIDONE vs CHOLECALCIFEROL
CHLORTHALIDONE vs CHOLECALCIFEROL\ERGOCALCIFEROL
CHLORTHALIDONE vs CHOLESTYRAMINE
CHLORTHALIDONE vs CHOLIC ACID